The World Health Organization, also known as the “WHO”, commenced an insulin pre-qualification program.
It was introduced on 13 November 2019 to help provide treatment for diabetes in developing countries.
According to Dr. Tedros Adhanom (WHO general director), “Diabetes is on the rise globally and rising faster in low-income countries. Too many people who need insulin encounter financial hardship in accessing it or go without it and risk their lives.”
The insulin pre-qualification program aims to ensure that everyone who needs it has access to it.
Data collected by WHO between 2016-2019 indicates that insulin was only accessible to 61% and 13% in health facilities, respectively among 24 countries in the 4 continents.
In addition, data shows that in developing countries like Ghana, 22% of a regular employee’s salary is only able to supply one month of insulin treatment.
In developed countries, people often must fraction their insulin which can have harmful after-effects as they do not get the right quantity needed.
Over 420 million people have diabetes, the insulin pre-qualification program hopes to increase accessibility and affordability whilst ensuring the quality and the ample supply across the world.